In addition, AstraZeneca, Daiichi Sankyo, and the pan-Canadian Pharmaceutical Alliance (pCPA) have signed a Letter of Intent under the Temporary Access Process (pTAP). Together with the TLR, this ...

Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

Geoffrey Porges, a longtime biotech analyst and well-known Wall Street figure, stepped down as CFO of the New York biotech ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

The Trust Hospital has called for better access to inhale medications for asthma patients in Ghana. Dr. Juliana Oye Ameh, Chief Executive Officer of Trust Hospital, described asthma as a pressing ...

Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New ...

When Stephen Wright asked AI which UK shares he should take a look at, the number one choice is a stock that wasn’t even on ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...